| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Piperlongumine | Acute Pancreatitis | 1 | PM | 36951266 | 📋 | Effects of piperlonguminine on lung injury in severe acute pancreatitis via the TLR4/NF-κB pathway |
| Piperlongumine | Biliary Tract Cancer | 1 | PM | 36227332 | 📋 | Piperlongumine and bortezomib synergically inhibit cholangiocarcinoma via ER stress-induced cell death |
| Piperlongumine | Colon Cancer | 2 | PM | 37833257 | 📋 | Combination therapy with HSP90 inhibitors and piperlongumine promotes ROS-mediated ER stress in colon cancer cells |
| Piperlongumine | Colon Cancer | 1 | PM | 33433833 | 📋 | Piperlongumine targets NF-κB and its downstream signaling pathways to suppress tumor growth and metastatic potential in experimental colon cancer |
| Piperlongumine | Esophageal Cancer | 1 | PM | 38242274 | 📋 | Piperlongumine inhibits esophageal squamous cell carcinoma in vitro and in vivo by triggering NRF2/ROS/TXNIP/NLRP3-dependent pyroptosis |
| Piperlongumine | Gastric Cancer | 1 | PM | 35481419 | 📋 | Piperlongumine combined with vitamin C as a new adjuvant therapy against gastric cancer regulates the ROS-STAT3 pathway |
| Piperlongumine | Liver Cancer | 3 | PM | 35539886 | 📋 | Molecular docking analysis of piperlongumine with different apoptotic proteins involved in Hepatocellular Carcinoma |
| Piperlongumine | Liver Cancer | 2 | PM | 35202819 | 📋 | Piperlongumine Synergistically Enhances the Antitumour Activity of Sorafenib by Mediating ROS-AMPK Activation and Targeting CPSF7 in Liver Cancer |
| Piperlongumine | Liver Cancer | 1 | PM | 35113675 | 📋 | Piperlongumine inhibits diethylnitrosamine induced hepatocellular carcinoma in rats |
| Piperlongumine | Oral Cancer | 3 | PM | 38452870 | 📋 | Anti-cancer agent piperlongumine is an inhibitor of transient receptor potential melastatin 7 channel in oral squamous cell carcinoma |
| Piperlongumine | Oral Cancer | 2 | PM | 37969394 | 📋 | Natural product piperlongumine inhibits proliferation of oral squamous carcinoma cells by inducing ferroptosis and inhibiting intracellular antioxidant capacity |
| Piperlongumine | Oral Cancer | 1 | PM | 37760883 | 📋 | Piperlongumine Induces Apoptosis and Cytoprotective Autophagy via the MAPK Signaling Pathway in Human Oral Cancer Cells |
| Piperlongumine | Pancreatic Cancer | 1 | PM | 26667450 | 📋 | Piperlongumine Suppresses Growth and Sensitizes Pancreatic Tumors to Gemcitabine in a Xenograft Mouse Model by Modulating the NF-kappa B Pathway |
